Merck (MRK) Inventory (2009 - 2026)

Merck (MRK) has 18 years of Inventory data on file, last reported at $6.5 billion in Q1 2026.

• Inventory for Q1 2026 came in at $6.5 billion, up 4.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.5 billion (up 4.57% YoY), and the FY2025 annual result was $6.7 billion, up 8.99% from the prior year.
• Inventory declined to $6.5 billion in Q1 2026 per MRK's latest filing, from $6.7 billion in the prior quarter.
• Over five years, Inventory peaked at $6.7 billion in Q4 2025 and troughed at $5.5 billion in Q2 2022.
• A 5-year average of $6.2 billion and a median of $6.2 billion in 2025 frame the typical range for Inventory.
• The sharpest annual moves came in 2022 and 2024: Inventory slipped 9.81% in 2022, then grew 11.04% in 2024.
• A 5-year view of Inventory shows it stood at $5.9 billion in 2022, then advanced by 7.56% to $6.4 billion in 2023, then fell by 3.92% to $6.1 billion in 2024, then grew by 8.99% to $6.7 billion in 2025, then decreased by 2.69% to $6.5 billion in 2026.
• Business Quant data shows MRK's Inventory at $6.5 billion in Q1 2026, $6.7 billion in Q4 2025, and $6.4 billion in Q3 2025.